Preoperative characteristics | Â |
---|---|
Gender, n (% men) | 24 (80%) |
Age (year) | 68.0 ±1.71 |
Body weight (kg) | 87.4 ±2.95 |
Body surface area (m2) | 2.0 ±0.04 |
Preoperative left ventricular ejection fraction (%) | 43 ±3 |
Diabetes type 2, n (%) | 7 (23%) |
Hypertension, n (%) | 15 (50%) |
Preoperative serum creatinine (μmol/L) | 86.5 ±3.00 |
Preoperative Higgins risk score n = 19 | 3.6 ±0.46 |
Preoperative treatment: | Â |
   Angiotensin-converting enzyme inhibitor, n (%) | 18 (60%) |
   Beta-adrenergic blocker, n (%) | 24 (80%) |
   Calcium antagonists, n (%) | 3 (10%) |
Perioperative characteristics | Â |
Type of surgery | Â |
   Coronary artery bypass surgery, n (%) | 12 (40%) |
   Valve, n (%) | 5 (17%)) |
   Combined, n (%) | 7 (23%) |
   Other, n (%) | 4 (13%) |
   Redo CABG/Valve | 2 (7%) |
Nonelectivea, n (%) | 9 (30%) |
Cardiopulmonary bypasstime (min) | 145.9 ± 12.65 |
Aortic cross clamp time (min) | 81.8 ± 8.88 |
Intensive care unit Higgins risk score | 9.1 ± 0.93 |
Postoperative (day 1) serum creatinine (μmol/L) | 119.2 ±5.59 |